This statistic shows the revenue and operating profit of the top four pharmaceutical companies in Japan in fiscal year 2010/11. In that year, the Japanese drugmaker Takeda generated a revenue of 16.6 billion U.S. dollars.
Revenue and operating profit of the top four pharmaceutical companies in Japan in fiscal year 2010/11 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Scandinavia
Pharmaceutical sales
8
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2021
- Basic Statistic Value of pharmaceutical sales in Norway 2008-2021
- Basic Statistic Value of pharmaceutical sales in Sweden 2000-2021
- Basic Statistic Sales of pharmaceuticals in Norway 2020-2021, by prescription type
- Basic Statistic Revenue of pharmaceuticals in Sweden by type 2021
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2021
- Basic Statistic Revenue of pharmaceuticals in Norway by drug category 2020
- Basic Statistic Largest pharmaceutical classes in Sweden 2021, by sales value
Patents and clinical trials
6
- Basic Statistic Number of applications for clinical trials in Denmark 2013-2021, by sponsor
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021, by type of actor
- Premium Statistic Number of applications for clinical trials in Sweden 2014-2021, by sponsor
- Basic Statistic Number of biotechnology patents in Denmark 2011-2019
- Basic Statistic Number of biotechnology patents in Norway 2011-2019
- Basic Statistic Number of biotechnology patents in Sweden 2011-2019
Trade
5
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2021
- Basic Statistic Import and export value of basic pharmaceutical products in Norway 2009-2021
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2021
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2021
- Basic Statistic Export value of pharmaceuticals from Sweden 2012-2021
Key players
6
Further related statistics
11
- Pharmaceutical companies in Japan: Revenue by Region
- GAAP earnings - adjustments of selected U.S. pharmaceutical companies 2011
- Global proportion of researchers at pharma companies with dual relationships 2014
- Growth of top pharmaceutical companies in South Africa in 2014-2015
- Business risks at selected pharmaceutical companies 2011
- Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016
- Quickness of financial reporting of selected pharmaceutical companies - U.S. 2012
- M&A capacities - changes for the global pharma industry 2008-2015
- Value of Novartis' pharmaceuticals exported from Spain 2012-2016
- R&D expenditure of pharmaceutical companies in China 2014-2023
- 1-year probability of default median for public U.S. healthcare industries 2020-2021
Further Content: You might find this interesting as well
Statistics
- Pharmaceutical companies in Japan: Revenue by Region
- GAAP earnings - adjustments of selected U.S. pharmaceutical companies 2011
- Global proportion of researchers at pharma companies with dual relationships 2014
- Growth of top pharmaceutical companies in South Africa in 2014-2015
- Business risks at selected pharmaceutical companies 2011
- Lease expenses of selected U.S. pharmaceutical companies 2011 and 2016
- Quickness of financial reporting of selected pharmaceutical companies - U.S. 2012
- M&A capacities - changes for the global pharma industry 2008-2015
- Value of Novartis' pharmaceuticals exported from Spain 2012-2016
- R&D expenditure of pharmaceutical companies in China 2014-2023
- 1-year probability of default median for public U.S. healthcare industries 2020-2021
Handelsblatt. (June 8, 2011). Revenue and operating profit of the top four pharmaceutical companies in Japan in fiscal year 2010/11 (in billion U.S. dollars) [Graph]. In Statista. Retrieved February 01, 2023, from https://www.statista.com/statistics/273336/revenue-and-operating-profit-of-the-top-four-pharmaceutical-companies-in-japan/
Handelsblatt. "Revenue and operating profit of the top four pharmaceutical companies in Japan in fiscal year 2010/11 (in billion U.S. dollars)." Chart. June 8, 2011. Statista. Accessed February 01, 2023. https://www.statista.com/statistics/273336/revenue-and-operating-profit-of-the-top-four-pharmaceutical-companies-in-japan/
Handelsblatt. (2011). Revenue and operating profit of the top four pharmaceutical companies in Japan in fiscal year 2010/11 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: February 01, 2023. https://www.statista.com/statistics/273336/revenue-and-operating-profit-of-the-top-four-pharmaceutical-companies-in-japan/
Handelsblatt. "Revenue and Operating Profit of The Top Four Pharmaceutical Companies in Japan in Fiscal Year 2010/11 (in Billion U.S. Dollars)." Statista, Statista Inc., 8 Jun 2011, https://www.statista.com/statistics/273336/revenue-and-operating-profit-of-the-top-four-pharmaceutical-companies-in-japan/
Handelsblatt, Revenue and operating profit of the top four pharmaceutical companies in Japan in fiscal year 2010/11 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/273336/revenue-and-operating-profit-of-the-top-four-pharmaceutical-companies-in-japan/ (last visited February 01, 2023)
Revenue and operating profit of the top four pharmaceutical companies in Japan in fiscal year 2010/11 (in billion U.S. dollars) [Graph], Handelsblatt, June 8, 2011. [Online]. Available: https://www.statista.com/statistics/273336/revenue-and-operating-profit-of-the-top-four-pharmaceutical-companies-in-japan/